Suggested Topics within your search.
Suggested Topics within your search.
- Health 8
- methods 8
- Research 6
- Physical fitness 5
- Consumers 4
- Conversation analysis 4
- Anesthesia 3
- Anesthetics 3
- Chemistry, Physical and theoretical 3
- Economic aspects 3
- History and criticism 3
- Moral and ethical aspects 3
- Nursing 3
- Psychological aspects 3
- Adulthood 2
- Application software 2
- Biochemistry 2
- Chemistry, Clinical 2
- Commercial law 2
- Computer-assisted instruction 2
- Education, Elementary 2
- Educational technology 2
- English language 2
- French language 2
- Geography 2
- Health and Fitness 2
- History 2
- Information technology 2
- Internet in education 2
- Internet in public administration 2
-
5041
EDUCATION SYSTEM IN PEOPLE'S REPUBLIC OF CHINA: STRUCTURE AND MAIN DIRECTIONS OF DEVELOPMENT
Published 2017-09-01Subjects: Get full text
Article -
5042
Compte rendu de Aron (Paul) et Vanderpelen-Diagre (Cécile), Edmond Picard (1836-1924)....
Published 2015-02-01Get full text
Article -
5043
-
5044
Safety, Tolerability, and Immunogenicity of the Invaplex<sub>AR-Detox</sub> <i>Shigella</i> Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
Published 2025-01-01“…This article describes the protocol of a study that will be the first to assess the safety, tolerability, and immunogenicity of Invaplex<sub>AR-Detox</sub> co-administered with dmLT in healthy adults in low-endemic and high-endemic settings. Methods: In a multi-center, randomized, double-blind, and placebo-controlled dose-escalation phase Ia/b trial, the safety, tolerability, and immunogenicity of three intramuscular vaccinations administered 4 weeks apart with 2.5 µg or 10 µg of Invaplex<sub>AR-Detox</sub> vaccine, alone or in combination with 0.1 µg of the dmLT adjuvant, will first be assessed in a total of 50 healthy Dutch adults (phase Ia) and subsequently in 35 healthy Zambian adults (phase Ib) aged 18–50 years. …”
Get full text
Article -
5045
-
5046
-
5047
Heritage Building of Residensi Tunku Abdul Rahman: Preserve and Conserve for The Future
Published 2024-01-01Get full text
Article -
5048
The Performance of Beethoven’s “Diabelli Variations”. Continuity, Discontinuity, Cyclic Integration, Irony
Published 2021-11-01Subjects: Get full text
Article -
5049
Guillon Jean-Marie, Paul-Albert Février, un historien dans l’Algérie en guerre....
Published 2010-12-01Get full text
Article -
5050
-
5051
-
5052
-
5053
Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine
Published 2025-12-01“…Background Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection, hospitalisation and death in adults.Methods Based on evidence regarding the impact of RSV on adult populations at risk for severe infection and the efficacy and safety of RSV vaccines, the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine endorses this position paper with recommendations to prevent RSV-associated disease and its complications in adults through vaccination.Conclusion The RSV vaccine is recommended for people aged ≥50 years with risk factors (chronic obstructive pulmonary disease, asthma, heart failure, coronary artery disease, diabetes, chronic kidney disease, chronic liver disease, immunocompromise, frailty, dementia, and residence in a nursing home) and all persons aged ≥60 years. …”
Get full text
Article -
5054
-
5055
-
5056
-
5057
Vegetation disturbance and regrowth dynamics in shifting cultivation landscapes
Published 2024-11-01Get full text
Article -
5058
-
5059
-
5060